이상반응 보고
VAERS ID | 2297440 |
---|---|
성별 | 여성 |
나이 | 73세 |
주 코드 | FR |
제약회사 | JANSSEN |
로트 번호 | ACB6894 |
예방접종 횟수 | 1 |
접종일 | |
발병일 | 2022-02-08 |
상태 | 사망 |
증상
- 뇌혈관 사고(Cerebrovascular accident)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
CVA; This spontaneous report received from a health care professional by a Regulatory Authority (PHIFDA, PH-PHFDA-300146397) concerned a 74 year old female of an unspecified race and ethnicity.
The patient's height, and weight were not reported.
No past medical history or concurrent conditions were reported.
The patient received covid-19 vaccine ad26.
cov2.
s (suspension for injection, intramuscular, batch number: ACB6894, expiry: unknown) dose was not reported, 1 total, administered on 21-JAN-2022 for an unspecified indication.
Age at time of vaccination 73 years old.
No concomitant medications were reported.
On 08-FEB-2022, the patient experienced CVA (cerebrovascular accident) which resulted in death.
It was unknown whether autopsy was done.
The action taken with covid-19 vaccine ad26.
cov2.
s was not applicable.
This report was serious (Death).
; Sender's Comments: V0: 20220543904-covid-19 vaccine ad26.
cov2.
s-CVA.
The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility.
There is no information on any other factors potentially associated with the event(s).
Therefore, this event(s) is considered unassessable.
; Reported Cause(s) of Death: CVA